Advanced Materials Technologies,
Journal Year:
2023,
Volume and Issue:
8(11)
Published: April 4, 2023
Abstract
The
SARS‐CoV‐2
pandemic
caused
a
public
health
crisis
throughout
the
world
and
highlighted
need
for
rapid
sensitive
testing
as
countermeasure.
A
specific
biosensor
platform
is
developed
detection
of
antigen
RNA
SARS‐CoV‐2,
its
variant
(B1.1.529).
demonstrated
combines
unique
protein
catalyzed
capture
bioreceptors
(PCCs)
chimeric
(RNA‐DNA)
probe
using
LwaCas13a
collateral
cleavage
activity
atop
graphene
field
effect
transistors
(gFETs).
reported
able
to
differentiate
unprocessed
10
4
pfu
m
−1
samples
from
Influenza
Rhinovirus.
limit
(LOD)
calculated
3
in
buffer
PFU
mL
10%
saliva,
while
LOD
≈65
viral
isolate
without
amplification.
To
provide
high
reliability
detection,
role
internal
external
factors
with
respect
gate
voltage
further
analyzed
by
Principal
Component
Analysis
(PCA).
Based
on
PCA
analysis,
authors
are
classify
pathogen
positive
or
negative
(
Y
>
0:
Positive
pathogen,
<
Negative
pathogen).
can
be
quickly
adapted
multi‐omics
multiplexed
diagnosis
continuously
evolving
biothreats
global
pandemics.
Angewandte Chemie International Edition,
Journal Year:
2023,
Volume and Issue:
62(17)
Published: Jan. 30, 2023
Abstract
Polymerase
chain
reaction
(PCR)‐based
nucleic
acid
testing
has
played
a
critical
role
in
disease
diagnostics,
pathogen
surveillance,
and
many
more.
However,
this
method
requires
long
turnaround
time,
expensive
equipment,
trained
personnel,
limiting
its
widespread
availability
diagnostic
capacity.
On
the
other
hand,
clustered
regularly
interspaced
short
palindromic
repeats
(CRISPR)
technology
recently
demonstrated
capability
for
detection
with
high
sensitivity
specificity.
CRISPR‐mediated
biosensing
holds
great
promise
revolutionizing
procedures
developing
point‐of‐care
diagnostics.
This
review
focuses
on
recent
developments
both
fundamental
CRISPR
biochemistry
CRISPR‐based
techniques.
Four
ongoing
research
hotspots
molecular
diagnostics‐target
preamplification‐free
detection,
microRNA
(miRNA)
testing,
non‐nucleic‐acid
SARS‐CoV‐2
detection‐are
also
covered.
Angewandte Chemie International Edition,
Journal Year:
2022,
Volume and Issue:
61(32)
Published: May 12, 2022
The
clustered
regularly
interspaced
short
palindromic
repeats
(CRISPR)/CRISPR-associated
(Cas)
systems
have
recently
received
notable
attention
for
their
applications
in
nucleic
acid
detection.
Despite
many
attempts,
the
majority
of
current
CRISPR-based
biosensors
infectious
respiratory
disease
diagnostic
still
require
target
preamplifications.
This
study
reports
a
new
biosensor
amplification-free
detection
via
harnessing
trans-cleavage
mechanism
Cas13a
and
ultrasensitive
graphene
field-effect
transistors
(gFETs).
CRISPR
Cas13a-gFET
achieves
SARS-CoV-2
syncytial
virus
(RSV)
genome
down
to
1
attomolar
without
Additionally,
we
validate
performance
using
clinical
samples,
including
those
with
low
viral
loads
(Ct
value
>30).
Overall,
these
findings
establish
our
among
most
sensitive
platforms
date.
Nature Communications,
Journal Year:
2024,
Volume and Issue:
15(1)
Published: April 16, 2024
Abstract
The
emerging
monkeypox
virus
(MPXV)
has
raised
global
health
concern,
thereby
highlighting
the
need
for
rapid,
sensitive,
and
easy-to-use
diagnostics.
Here,
we
develop
a
single-step
CRISPR-based
diagnostic
platform,
termed
SCOPE
(Streamlined
CRISPR
On
Pod
Evaluation
platform),
field-deployable
ultrasensitive
detection
of
MPXV
in
resource-limited
settings.
viral
nucleic
acids
are
rapidly
released
from
rash
fluid
swab,
oral
saliva,
urine
samples
2
min
via
streamlined
lysis
protocol,
followed
by
10-min
recombinase
polymerase
amplification
(RPA)-CRISPR/Cas13a
reaction.
A
pod-shaped
vest-pocket
analysis
device
achieves
whole
process
reaction
execution,
signal
acquisition,
result
interpretation.
can
detect
as
low
0.5
copies/µL
(2.5
copies/reaction)
within
15
sample
input
to
answer.
We
validate
developed
assay
on
102
clinical
male
patients
/
volunteers,
testing
results
100%
concordant
with
real-time
PCR.
single-molecular
level
sensitivity
minutes
simplified
procedure
performed
miniaturized
wireless
device,
which
is
expected
spur
substantial
progress
enable
practice
application
diagnostics
techniques
point-of-care
setting.
Advanced Functional Materials,
Journal Year:
2024,
Volume and Issue:
34(48)
Published: June 29, 2024
Abstract
While
existing
polyoxometalates
(POMs)
are
predominantly
utilized
in
a
range
of
energy
devices,
their
potential
bioelectronics
and
optoelectronics,
particularly
organic
photoelectrochemical
transistors
(OPECTs),
remains
unexplored.
Here,
the
POMs
this
aspect
is
unveiled
by
POM/sulfide‐gated
OPECT.
The
representative
PW
12
/ZnIn
2
S
4
with
cascading
light‐harvesting
enzyme‐like
functionality
enables
unique
on‐off
OPECT
operation.
incorporation
facilitates
separation
photogenerated
charge
carriers
across
heterojunction
interface,
consequently
inducing
pronounced
gating
effect.
Linking
CRISPR/Cas13a
system
correlating
target
miRNA‐21
biological
generation
H
O
,
will
enable
polymerization
dopamine
into
polydopamine
thus
sensitively
inhibit
gating.
Experimental
results
demonstrated
that
developed
sensor
achieved
good
analytical
performance
detection
limit
as
low
3.9
f
m
.
This
study
demonstrates
Given
large
family
multifunction
POMs,
its
implications
diverse
optoelectronics
expected.
Advanced Functional Materials,
Journal Year:
2024,
Volume and Issue:
34(44)
Published: May 22, 2024
Abstract
Recently,
field‐effect
transistors
(FETs)
have
emerged
as
a
novel
type
of
multiparameter,
high‐performance,
highly
integrated
platform
for
biochemical
detection,
leveraging
their
classical
three‐terminal
structure,
working
principles,
and
fabrication
methods.
Notably,
graphene
materials,
known
exceptional
electrical
optical
properties
well
biocompatibility,
serve
fundamental
component
these
devices,
further
enhancing
advantages
in
biological
detection.
This
review
places
special
emphasis
on
recent
advancements
transistor
(GFET)‐based
biosensors
focuses
four
main
areas:
i)
the
basic
concepts
FETs
specific
GFETs;
ii)
various
state‐of‐the‐art
approaches
to
enhance
performance
GFET‐based
terms
operating
principles
“3S”—stability,
sensitivity,
specificity;
iii)
multiplexed
detection
strategies
biosensors;
iv)
current
challenges
future
perspectives
field
biosensors.
It
is
hoped
that
this
article
can
profoundly
elucidate
development
GFET
inspire
broader
audience.
Materials,
Journal Year:
2024,
Volume and Issue:
17(2), P. 333 - 333
Published: Jan. 9, 2024
Owing
to
its
outstanding
physical
properties,
graphene
has
attracted
attention
as
a
promising
biosensor
material.
Field-effect-transistor
(FET)-based
biosensors
are
particularly
because
of
their
high
sensitivity
that
is
achieved
through
the
carrier
mobility
graphene.
However,
graphene-FET
have
not
yet
reached
widespread
practical
applications
owing
several
problems.
In
this
review,
authors
focus
on
and
discuss
advantages,
challenges
development,
solutions
challenges.
The
problem
Debye
screening,
in
which
surface
charges
detection
target
shielded
undetectable,
can
be
solved
by
using
small-molecule
receptors
deformations
enzyme
reaction
products.
To
address
complexity
sample
components
mechanisms
biosensors,
outline
measures
against
nonspecific
adsorption
remaining
problems
related
mechanism
itself.
also
introduce
solution
with
molecular
species
reach
sensor
surfaces
limited.
Finally,
present
multifaceted
approaches
provide
much
information
corroborate
results
electrical
measurements.
introduced
bring
us
closer
realization
stable
utilizing
superior
characteristics
Nanoscale,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 1, 2025
Current
molecular
tests
for
tuberculosis
(TB),
such
as
whole
genome
sequencing
and
Xpert
Mycobacterium
tuberculosis/rifampicin
resistance
assay,
exhibit
limited
sensitivity
necessitate
the
pre-amplification
step
of
target
DNA.
This
limitation
greatly
increases
detection
time
poses
an
increased
risk
infection.
Here,
we
present
a
graphene
field-effect
transistor
(GFET)
based
on
CRISPR/Cas
system
detecting
tuberculosis.
The
CRISPR/Cas12a
has
ability
to
specifically
recognize
cleave
By
integrating
onto
FET
platform
utilizing
its
electrical
amplification
capability,
achieve
rapid
sensitive
without
requiring
sample
pre-amplification,
with
limit
(LoD)
low
2.42
×
10-18
M.
Cas12a-GFET
devices
can
differentiate
30
positive
cases
from
56
serum
samples
within
5
minutes.
These
findings
highlight
immense
potential
in
future
biological
analysis
clinical
diagnosis.
Frontiers in Microbiology,
Journal Year:
2022,
Volume and Issue:
13
Published: Dec. 8, 2022
The
clustered
regularly
interspaced
short
palindromic
repeats
(CRISPR)
system
is
a
natural
adaptive
immune
of
prokaryotes.
CRISPR-Cas
currently
divided
into
two
classes
and
six
types:
types
I,
III,
IV
in
class
1
systems
II,
V,
VI
2
systems.
Among
the
type
systems,
CRISPR/Cas13a
has
been
most
widely
characterized
for
its
application
molecular
diagnostics,
gene
therapy,
editing,
RNA
imaging.
Moreover,
because
trans-cleavage
activity
Cas13a
high
specificity
CRISPR
RNA,
enormous
potential
field
diagnostics.
Herein,
we
summarize
applications
detection
pathogens,
including
viruses,
bacteria,
parasites,
chlamydia,
fungus;
biomarkers,
such
as
microRNAs,
lncRNAs,
circRNAs;
some
non-nucleic
acid
targets,
proteins,
ions,
methyl
groups.
Meanwhile,
highlight
working
principles
novel
Cas13a-based
methods,
Specific
High-Sensitivity
Enzymatic
Reporter
UnLOCKing
(SHERLOCK)
improved
versions,
nucleic
amplification-free
biosensors,
biosensors
target
detection.
Finally,
focus
on
issues
that
need
to
be
solved
development
prospects
system.